Jon Hamilton

Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience, health risks, and extreme weather.

Following the 2011 earthquake and tsunami in Japan, Hamilton was part of NPR's team of science reporters and editors who went to Japan to cover the crisis at the Fukushima Dai-ichi nuclear power plant.

Hamilton contributed several pieces to the Science Desk series "The Human Edge," which looked at what makes people the most versatile and powerful species on Earth. His reporting explained how humans use stories, how the highly evolved human brain is made from primitive parts, and what autism reveals about humans social brains.

In 2009, Hamilton received the Michael E. DeBakey Journalism Award for his piece on the neuroscience behind treating autism.

Before joining NPR in 1998, Hamilton was a media fellow with the Henry J. Kaiser Family Foundation studying health policy issues. He reported on states that have improved their Medicaid programs for the poor by enrolling beneficiaries in private HMOs.

From 1995-1997, Hamilton wrote on health and medical topics as a freelance writer, after having been a medical reporter for both The Commercial Appeal and Physician's Weekly.

Hamilton graduated with honors from Oberlin College in Ohio with a Bachelor of Arts degree in English. As a student, he was the editor of the Oberlin Review student newspaper. He earned his master's degree in journalism from Columbia University, where he graduated with honors During his time at Columbia, Hamilton was awarded the Baker Prize for magazine writing and earned a Sherwood traveling fellowship.

An online contest for data scientists has produced a great leap forward in efforts to predict when someone with epilepsy is going to have a seizure. The winning team used data on electrical activity in the brain to develop an algorithm that predicted seizures 82 percent of the time.

Bob Smithson had been in the critical care unit at Brigham and Women's Hospital in Boston for more than a week. He had a rare neuromuscular disease, and his 78-year-old body was being kept alive by tubes that delivered air to his lungs and food to his stomach.

Then Bob's wife, Pat, got some really disturbing news. The hospital's medical staff wanted Bob to have a tracheostomy, a surgical procedure that would carve a hole in his neck and allow doctors to keep him on a breathing machine indefinitely.

A scientist who chose to ignore the mainstream nearly 30 years ago has found a new way to regenerate nerves in the spinal cord, at least in animals. A drug that Jerry Silver, a professor of neuroscience at Case Western Reserve University, helped design a drug that has allowed paralyzed rats to regain bladder function and even walk.

A brain area that recognizes faces remains functional even in people who have been blind since birth, researchers say. The finding, presented at the Society for Neuroscience meeting this week, suggests that facial recognition is so important that evolution has hardwired it into the human brain.

Almost a century after the discovery that sleep helps us remember things, scientists are beginning to understand why.

During sleep, the brain produces chemicals that are important to memory and relives events we want to remember, scientists reported this week at the Society for Neuroscience meeting in Washington D.C.

Ebola is threatening to reverse years of educational progress in West Africa. The virus has kept school closed for months in a part of the world where literacy rates are low and school systems are only now recovering from years of civil war.

In Liberia, many children have been put to work while schools are closed, and Ebola is hurting the economy, says Laurent Duvillier, a communication specialist at UNICEF. The fear now, he says, is that many of these children will never return to school.

In one corner of Liberia, a community has come together to change the course of the deadly epidemic. New cases have been brought to a standstill. This success shows that it's going to take more than extra beds at a ward to stop Ebola.

When Doctors Without Borders arrived in the northern district of Foya in early August, Ebola was out of control. Foya was the first area in Liberia to report cases, and the community has been hit hard.

When Ebola began killing people in the Monrovia suburb of Clara Town several months ago, some residents blamed vaccines.

One vaccinator in the town says mothers didn't want her near their babies.

"They had a notion that when the people come to the hospital, we would inject them and kill them," says vaccinator Che Che Richardson at the Clara Town Health Center, "because it was the hospital giving the people Ebola."

Rumors like that, combined with the closing of many health facilities, have caused childhood vaccination rates to plummet in Liberia.

Ebola has killed more than 1,300 people in Liberia's capital of Monrovia. But for the million-plus residents who aren't sick, life goes on even as their city is reshaped by death.

On market day, the downtown is teeming with shoppers and merchants and people just hanging out. It almost looks like commerce as usual until you notice all the "Ebola buckets," elevated plastic containers with spigots that deliver a chlorine solution for hand-washing.

Night clubs have shut their doors. Soccer leagues have been suspended. And a strict curfew is keeping the streets empty at night.

But there's one place in Monrovia where people continue to gather despite the threat of Ebola: Sunday church service.

Eighteen months after its launch, President Obama's plan to explore the mysteries of the human brain is finally taking shape. During separate events Tuesday, the White House and National Institutes of Health offered details about which projects are being funded and why.

At a morning press conference, NIH officials announced $46 million in grant awards to more than 100 investigators. Most of the researchers are working on tools that can "transform how we study the brain," said NIH Director Francis Collins.

The heavyset man with a bandage on his throat is having trouble repeating a phrase. "No ifs ..." he says to the medical students and doctors around his bed at Brigham and Women's Hospital in Boston.

"Can I hear you say no ifs, ands or buts?" says Dr. Allan Ropper, the Harvard neurologist in charge. The patient tries again. "No ifs, buts, ands or," he says.

If you're a regular Shots reader or Morning Edition listener, you may remember a recent story about Justin McCowan, a man with Down syndrome who wanted to help researchers find a treatment for Alzheimer's disease. McCowan died in his sleep on Thursday at his home in Santa Monica, Calif. He was 40.

Dan Reiter, 37, is a long-board surfer and contractor who used to live in Tampa, Fla. Then he discovered the surf breaks along a stretch of coast south of Cape Canaveral. "It's one of the most beautiful places in the world to live and surf and raise your kids," says Reiter, 37, as we watch head-high waves roll into Hightower Beach.

But there's trouble in this coastal paradise. It's on a low-lying barrier island that's getting lower as sea level rises. So the cities here are looking for ways to keep the water at bay or retreat from it.

When researchers at the University of California, San Diego wanted to study an experimental Alzheimer's drug last year, they sought help from an unlikely group: people with Down syndrome.

Pages